The Ozempic Controversy: A Magic Bullet for Weight Loss or Potential Health Risks? | George Kramb, PatientPartner

Join host Steve Martorano in this episode of The Behavioral Corner as he delves into the latest buzz surrounding Ozempic, a drug initially intended for treating type two diabetes but gaining popularity as a potential weight loss miracle. Steve is joined by George Kramb, co-founder of the patient advocacy group PatientPartner, who sheds light on the drug's efficacy and the unexpected side effects it brings.

-------------------------------
The Behavioral Corner is produced in partnership with Retreat Behavioral Health -- where healing happens.